Jubilant partners US Eli Lilly for drug development

New Delhi, Oct 3 (UNI) Jubilant Organosys Ltd today said it has formed a joint venture (JV) with the US-based Eli Lilly for providing drug development services to the companies' partnered molecules.

The JV will be based in Bangalore and is expected to begin operations in the fall of 2008, the companies said in a joint statement.

The venture will focus on providing pre clinical work and developing the molecules through to phase two clinical testing.

UNI AK MP VC2022